768 papers found
Refreshing results…
Urinary miR-183 and miR-205 do not surpass PCA3 in urine as predictive markers for prostate biopsy outcome despite their highly dysregulated expression in prostate cancer tissue
Urinary thiosulfate as failed prostate cancer biomarker – an exemplary multicenter re-evaluation study
Staging lymphadenectomy in patients with localized high risk prostate cancer: comparison of the laparoendoscopic single site (LESS) technique with conventional multiport laparoscopy
Abstract 1415: Prostate cancer: An integrated evaluation of metabolomics, transcriptomics, and proteomics expression data
KDM5C Is Overexpressed in Prostate Cancer and Is a Prognostic Marker for Prostate-Specific Antigen-Relapse Following Radical Prostatectomy
Myoglobin expression in prostate cancer is correlated to androgen receptor expression and markers of tumor hypoxia.
Prostate-specific antigen and other serum and urine markers in prostate cancer
Serum testosterone improves the accuracy of Prostate Health Index for the detection of prostate cancer
Nucleic acid-based biomarkers in body fluids of patients with urologic malignancies
Nucleic acid-based tissue biomarkers of urologic malignancies*
Mp63-05 Serum Testosterone Improves the Accuracy of Prostate Health Index for the Detection of Prostate Cancer
The effect of [-2]proPSA and prostate health index (phi) on the accuracy of the prediction of initial and repeat prostate biopsies compared to tPSA and percent fPSA in young men (age 65 or younger).
Prognostic and diagnostic implications of epithelial cell adhesion/activating molecule (EpCAM) expression in renal tumours: a retrospective clinicopathological study of 948 cases using tissue microarrays: EpCAM expression in renal tumours
CD57 Expression in Incidental, Clinically Manifest, and Metastatic Carcinoma of the Prostate
Risk prediction models for biochemical recurrence after radical prostatectomy using prostate-specific antigen and Gleason score
The Antiapoptotic Function of miR-96 in Prostate Cancer by Inhibition of FOXO1
Renal cell neoplasias: reversion-inducing cysteine-rich protein with Kazal motifs discriminates tumor subtypes, while extracellular matrix metalloproteinase inducer indicates prognosis
MicroRNA Signature Helps Distinguish Early from Late Biochemical Failure in Prostate Cancer
Tissue metabolite profiling identifies differentiating and prognostic biomarkers for prostate carcinoma
Figure S3
Missing publications? Read more about our data sources.